The Food and Drug Administration on Friday approved rheumatoid arthritis drug golimumab marketed...
|
A new study published in the April edition of the journal Archives of Dermatology concludes that...
|
The FDA issued a public health advisory February 19th regarding reports of a rare brain infection...
|
Three patients taking Genentech’s psoriasis drug Raptiva are thought to have died of...
|
The Food and Drug Administration wants additional information on Ustekinumab before approving it...
|
Centocor Inc., a unit of Johnson & Johnson, announced yesterday that federal health regulators...
|
The FDA declined the approval of Johnson & Johnson’s ne anti-inflammatory drug,...
|
The Food and Drug
Administration announced today that the label of Genentech Inc's psoriasis...
|
Johnson & Johnson introduced an experimental drug called ustekinumab that is said to show...
|
A recent short term trial reached the conclusion that an experimental drug called Ustekinumab,...
|
Johnson & Johnson unveiled Thursday results of a
late-stage trial that showed its psoriasis...
|
The U.S. Food and Drug Administration issued a statement which highlights that manufacturers of...
|
The Food and Drug Administration ordered
stronger warnings about the risk of potentially deadly...
|
A Food and Drug Administration advisory panel said Wednesday that wider use of Amgen Inc’s...
|
A FDA panel recommended that the psoriasis drug Enbrel should
be approved for the treatment of the...
|
Recombinant-DNA drug Enbrel, made by Amgen, is apparently worrying the U.S. Food and Drug...
|
The FDA reviwers noted in a analysis released on Friday that
the experimental psoriasis drug,...
|
The U.S. Food and Drug Administration on Wednesday announced
a safety review of several drugs...
|
Amgen Inc and Wyeth’s Enbrel arthritis and psoriasis drug
will carry a new “black box” warning...
|
Amgen, a Thousand
Oaks, Calif., biotechnology
company and Wyeth Pharmaceuticals, a division of...
|
People suffering from severe psoriasis appear to die younger
than people who do not have the...
|